Apellis Pharmaceuticals
APLS
#2955
Rank
NZ$7.47 B
Marketcap
$60.12
Share price
-0.77%
Change (1 day)
-33.31%
Change (1 year)

Apellis Pharmaceuticals (APLS) Fails to deliver data

Key failure to deliver metrics for Apellis Pharmaceuticals:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Apellis Pharmaceuticals (APLS) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Apellis Pharmaceuticals (APLS) - since 2017

Volume in USD (price x number of shares), data since 2017

Apellis Pharmaceuticals (APLS) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024NZ$22.47 M-70.01%
2023NZ$74.94 M105.76%
2022NZ$36.42 M65.93%
2021NZ$21.95 M-45.06%
2020NZ$39.95 M228.46%
2019NZ$12.16 M-19.77%
2018NZ$15.16 M709.9%
2017NZ$1.87 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
NZ$1 MNZ$6 M๐Ÿ‡บ๐Ÿ‡ธ USA